Expanding Market Presence Human BioSciences is actively expanding its international footprint through strategic partnerships, such as recent collaborations with Skintech Medical Cosmetic Clinic in India and Skintech Green Ltd in Kenya, indicating growth opportunities in emerging markets for wound care solutions.

Product Innovation Opportunities With a diverse product portfolio including collagen sheets, particles, and gels for both human and veterinary use, there is significant potential to introduce new formulations or enhancements to meet specific healthcare facility needs and increase market share.

OTC Product Launch The company's upcoming OTC product line available on Amazon for human use suggests a direct-to-consumer sales channel that can be expanded further, providing opportunities to reach a broader customer base and facilitate brand recognition.

Healthcare Partner Networks Partnering with clinics, healthcare facilities, and doctor's offices positions Human BioSciences well to leverage existing medical networks, offering potential sales growth through B2B channels for new wound care products.

Targeting Therapeutic Segments Focusing on wound types from superficial to deep injuries provides multiple touchpoints within the wound care market, allowing for tailored sales strategies across hospitals, clinics, and specialty care centers seeking advanced collagen-based treatments.